Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5027 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 20 out of 28
279 citations found

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Polyclonal CD4+ T cell adoptive transfer:

    …In some cases, Foxp3-expressing Treg cells were ablated following adoptive transfer by the i.p. injection of diphtheria toxin (DT; List Biological, Campbell, CA) at a concentration of 0.5 g/mouse on day 1 after adoptive transfer of T cells, and then 0.2 g/mouse every other until day 21. …

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Mice and Reagents:

    … and Diphtheria toxin ( DT ) from Corynebacterium diphtheriae (no. 150) were purchased from List Biological Laboratories Inc.

    TLR stimulation induces a second wave of intimal CD11c+ cell reduction, not mediated by apoptosis, but is dependent on CCR7 and CCL19 expression:

    (a) … Positive controls were Cd11c-dtr transgenic mice injected with diphtheria toxin (DT) for 8h.

Stress-impaired transcription factor expression and insulin secretion in transplanted human islets

Dai, C;Kayton, NS;Shostak, A;Poffenberger, G;Cyphert, HA;Aramandla, R;Thompson, C;Papagiannis, IG;Emfinger, C;Shiota, M;Stafford, JM;Greiner, DL;Herrera, PL;Shultz, LD;Stein, R;Powers, AC;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Immunological Priming Requires Regulatory T Cells and IL-10-Producing Macrophages To Accelerate Resolution from Severe Lung Inflammation.

Aggarwal, NR;Tsushima, K;Eto, Y;Tripathi, A;Mandke, P;Mock, JR;Garibaldi, BT;Singer, BD;Sidhaye, VK;Horton, MR;King, LS;D'Alessio, FR;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • DT and clodronate liposome injections:

    DT (lot number 15043A1, diluted in PBS; List Biological Laboratories) was administered via i.p. injection on day 22 (50 mg/kg mouse) and day 21 (15 mg/kg) of the priming period prior to i.t. LPS as described previously (39). Mice harvested on day +5 also received a DT dose (15 mg/kg) on day +2 after i.t. LPS. Clodronate liposomes (Cl2MDP) or PBS liposomes (control) were prepared as previously described (8), followed by o.p. instillation (60 ml) on day 23, and i.p. injection (500 ml) on days 22 and 21 of the priming period.

Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming

D'Alessio, FR;Craig, JM;Singer, BD;Files, DC;Mock, JR;Garibaldi, BT;Fallica, J;Tripathi, A;Mandke, P;Gans, JH;Limjunyawong, N;Sidhaye, VK;Heller, NM;Mitzner, W;King, LS;Aggarwal, NR;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Diphtheria toxin and clodronate liposome injections:

    Diphtheria toxin (lot no. 15043A1; List Biological Laboratories) was diluted in PBS and administered via intraperitoneal injection on days 2 (50 g/kg mouse) and 1 (10 g/kg) before intratracheal LPS, and on days +1, +3, and +5 (10 g/kg) following intratracheal LPS as previously described (52). …

Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer

Griesmann, H;Drexel, C;Milosevic, N;Sipos, B;Rosendahl, J;Gress, TM;Michl, P;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors

Kalekar, LA;Schmiel, SE;Nandiwada, SL;Lam, WY;Barsness, LO;Zhang, N;Stritesky, GL;Malhotra, D;Pauken, KE;Linehan, JL;O'Sullivan, MG;Fife, BT;Hogquist, KA;Jenkins, MK;Mueller, DL;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Polyclonal CD4+ T cell adoptive transfer (in mice):

    Foxp3-expressing Treg cells were ablated following adoptive transfer by the i.p. injection of diphtheria toxin (DT; List Biological, Campbell, CA) at a concentration of 0.5 g/mouse on day 1 after adoptive transfer of T cells, and then 0.2 g/mouse every other until day 21.

Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It

Ali, JM;Negus, MC;Conlon, TM;Harper, IG;Qureshi, MS;Motallebzadeh, R;Willis, R;Saeb-Parsy, K;Bolton, EM;Bradley, JA;Pettigrew, GJ;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • In Vivo Depletion and Transfer of Donor and Recipient Leukocyte Subsets:

    Hematopoietic cells were depleted as previously described…by lethal irradiation (2  6.5 Gy) of donor mice 7 days before heart allograft procurement. B6.CD11c-DTR, BALB/c.CD11c-DTR, and CB6F1.CD11c-DTR donors and C57BL/6 (BL/6.CD11cDTR) chimeric heart graft recipients were treated with i.p. 32 ng/g DT (List Biological Laboratories) on days 5, 3, and 1 (donors) or thrice weekly in recipients.

CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice

Eldredge, LC;Treuting, PM;Manicone, AM;Ziegler, SF;Parks, WC;McGuire, JK;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo

Moro-Sibilot, L;This, S;Blanc, P;Sanlaville, A;Sisirak, V;Bardel, E;Boschetti, G;Bendriss-Vermare, N;Defrance, T;Dubois, B;Kaiserlian, D;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • In vivo treatments:

    To deplete pDCs, BDCA2-DTR mice were injected i.p. with 20 ng/g of DT (List Biological Laboratories, Campbell, CA, USA) on day 0 (or day 1 for oral immunization), then every other day with 10 ng/g. DT-treated WT littermates were used as controls. …CD4+ T-cell depletion was controlled in blood at day 0 before starting DT treatment and at sacrifice.